|
業務類別
|
Biotechnology |
|
業務概覽
|
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products. |
| 公司地址
| 490 Arsenal Way, Suite 120, Watertown, MA, USA, 02472 |
| 電話號碼
| +1 617 231-0700 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.c4therapeutics.com |
| 員工數量
| 104 |
| Ms. Kendra R. Adams |
Chief Financial Officer, Head of Corporate Affairs and Treasurer |
美元 506.83K |
29/04/2026 |
| Ms. Kelly A. Schick |
Chief People Officer |
-- |
29/04/2026 |
| Dr. Paige Mahaney, PhD |
Chief Scientific Officer |
-- |
29/04/2026 |
| Mr. Mark Mossler |
Chief Accounting Officer |
-- |
26/02/2026 |
| Mr. Scott N. Boyle, M.B.A.,PhD |
Chief Business Officer |
-- |
29/04/2026 |
| Mr. Andrew J. Hirsch |
Director, President and Chief Executive Officer |
美元 694.93K |
29/04/2026 |
| Dr. Leonard M.J. Reyno, M.D. |
Chief Medical Officer |
美元 597.74K |
29/04/2026 |
|
|
| Mr. Ronald Harold Wilfred Cooper |
Chairman of the Board |
29/04/2026 |
| Dr. Kenneth C. Anderson, M.D. |
Independent Director |
29/04/2026 |
| Dr. Laura Bessen, M.D. |
Independent Director |
29/04/2026 |
| Mr. Utpal Koppikar |
Independent Director |
29/04/2026 |
| Dr. Donna Roy Grogan, M.D. |
Independent Director |
29/04/2026 |
| Mr. Andrew J. Hirsch |
Director, President and Chief Executive Officer |
29/04/2026 |
| Dr. Stephen Fawell, PhD |
Independent Director |
29/04/2026 |
| Mr. Stephen L. Hoerter |
Independent Director |
29/04/2026 |
| Mr. Owen P. Hughes, Jr |
Independent Director |
29/04/2026 |
|
|
|
|
